UK markets open in 8 minutes
NIKKEI 225
39,173.15 +368.50 (+0.95%) HANG SENG
18,026.43 -1.28 (-0.01%) CRUDE OIL
81.62 -0.01 (-0.01%) GOLD FUTURES
2,337.60 -6.80 (-0.29%) DOW
39,411.21 +260.88 (+0.67%) Bitcoin GBP
48,134.98 -960.24 (-1.96%)
MIRM Jan 2025 20.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:53AM EDT. Market open.
| Previous close | 12.50 |
| Open | N/A |
| Bid | 6.00 |
| Ask | 10.40 |
| Strike | 20.00 |
| Expiry date | 2025-01-17 |
| Day's range | 12.50 - 12.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
ZacksMirum (MIRM) Soars on Interim Data From Liver Disease Studies
Mirum (MIRM) posts positive interim data from two phase IIb studies evaluating volixibat in patients with primary biliary cholangitis and primary sclerosing cholangitis. Stock rises.
ZacksMirum Pharmaceuticals (MIRM) Soars 27.3%: Is Further Upside Left in the Stock?
Mirum Pharmaceuticals (MIRM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Business WireMirum’s Volixibat Achieves Positive Interim Analyses in VANTAGE PBC and VISTAS PSC Studies
FOSTER CITY, Calif., June 17, 2024--Mirum’s Volixibat Achieves Positive Interim Analyses in VANTAGE PBC and VISTAS PSC Studies
© 2024 Yahoo. All rights reserved.